Northside Capital Management LLC lowered its stake in shares of CVS Health Corp (NYSE:CVS) by 8.6% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 11,618 shares of the pharmacy operator’s stock after selling 1,093 shares during the period. CVS Health comprises 0.4% of Northside Capital Management LLC’s portfolio, making the stock its 22nd largest holding. Northside Capital Management LLC’s holdings in CVS Health were worth $945,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently added to or reduced their stakes in the stock. Butensky & Cohen Financial Security Inc. lifted its holdings in shares of CVS Health by 12.3% in the third quarter. Butensky & Cohen Financial Security Inc. now owns 24,022 shares of the pharmacy operator’s stock valued at $1,953,000 after purchasing an additional 2,630 shares in the last quarter. Meeder Asset Management Inc. lifted its holdings in shares of CVS Health by 18,755.0% in the third quarter. Meeder Asset Management Inc. now owns 18,855 shares of the pharmacy operator’s stock valued at $1,533,000 after purchasing an additional 18,755 shares in the last quarter. Fisher Asset Management LLC lifted its holdings in shares of CVS Health by 0.5% in the third quarter. Fisher Asset Management LLC now owns 261,022 shares of the pharmacy operator’s stock valued at $21,226,000 after purchasing an additional 1,344 shares in the last quarter. Founders Capital Management lifted its holdings in shares of CVS Health by 6.6% in the third quarter. Founders Capital Management now owns 31,129 shares of the pharmacy operator’s stock valued at $2,531,000 after purchasing an additional 1,921 shares in the last quarter. Finally, Inverness Counsel LLC NY lifted its holdings in shares of CVS Health by 262.7% in the third quarter. Inverness Counsel LLC NY now owns 263,195 shares of the pharmacy operator’s stock valued at $21,403,000 after purchasing an additional 190,620 shares in the last quarter. 81.63% of the stock is currently owned by hedge funds and other institutional investors.

In related news, EVP Thomas M. Moriarty sold 20,547 shares of the company’s stock in a transaction that occurred on Monday, October 2nd. The shares were sold at an average price of $81.17, for a total transaction of $1,667,799.99. Following the completion of the transaction, the executive vice president now owns 43,178 shares of the company’s stock, valued at $3,504,758.26. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.61% of the company’s stock.

CVS Health Corp (NYSE CVS) opened at $72.31 on Wednesday. CVS Health Corp has a 52-week low of $66.45 and a 52-week high of $84.72. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.55 and a current ratio of 1.05. The company has a market cap of $72,601.13, a P/E ratio of 12.55, a P/E/G ratio of 1.34 and a beta of 0.89.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Monday, November 6th. The pharmacy operator reported $1.50 EPS for the quarter, topping the consensus estimate of $1.49 by $0.01. CVS Health had a net margin of 2.77% and a return on equity of 16.96%. The firm had revenue of $46.18 billion during the quarter, compared to analyst estimates of $46.17 billion. During the same quarter in the prior year, the business posted $1.64 earnings per share. CVS Health’s revenue for the quarter was up 3.5% compared to the same quarter last year. equities research analysts expect that CVS Health Corp will post 5.9 EPS for the current fiscal year.

Several analysts have issued reports on CVS shares. Robert W. Baird reaffirmed a “hold” rating and issued a $77.00 price target on shares of CVS Health in a report on Friday, October 27th. Needham & Company LLC raised shares of CVS Health from a “hold” rating to a “buy” rating and upped their price target for the company from $69.02 to $79.00 in a report on Friday, November 10th. Mizuho set a $90.00 price objective on shares of CVS Health and gave the company a “buy” rating in a research report on Tuesday, October 24th. BidaskClub lowered shares of CVS Health from a “hold” rating to a “sell” rating in a research report on Friday, August 25th. Finally, Loop Capital initiated coverage on shares of CVS Health in a research report on Thursday, August 24th. They issued a “hold” rating and a $83.00 price objective for the company. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and fourteen have given a buy rating to the company. CVS Health presently has an average rating of “Buy” and a consensus target price of $86.35.

COPYRIGHT VIOLATION WARNING: “CVS Health Corp (CVS) Shares Sold by Northside Capital Management LLC” was first published by Watch List News and is the property of of Watch List News. If you are accessing this article on another site, it was illegally stolen and reposted in violation of United States and international copyright & trademark legislation. The correct version of this article can be accessed at https://www.watchlistnews.com/cvs-health-corp-cvs-shares-sold-by-northside-capital-management-llc/1774158.html.

CVS Health Company Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.